Linaclotide

CAS 851199-59-2 12 API suppliersPeptide

Overview

Linaclotide is a guanylate cyclase-C agonist used to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. It works by increasing the secretion of chloride and bicarbonate into the intestinal lumen, resulting in increased intestinal fluid and accelerated transit.

API suppliers (12)

Suppliers of Linaclotide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
China7India2Netherlands1

Country recorded for 10 of 12 suppliers.

3 of 12 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (3 approved US products), the latest listed US patent on Linaclotide expires 16 Feb 2034 and exclusivity 21 May 2029. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

Gastroenterology
Verified Supplier Partner

Do you supply Linaclotide? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.